Here, we show that AZA responders have more
hematopoietic progenitor cells (HPCs) in the cell cycle.
Alternatively, embryonic stem (ES) cells have emerged as a potential source of less immunogenic
hematopoietic progenitor cells (HPCs).
Arndt K, Grinenko T, Mende N, Reichert D, Portz M, Ripich T, Carmeliet P, Corbeil D, Waskow C. CD133 is a modifier of
hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells.
The FDA has approved the use of stem cell - based products, including cord blood - derived
hematopoietic progenitor cells (blood forming stem cells) for many diseases.
The FLT3 - signaling pathway controls cell proliferation and survival, particularly of
hematopoietic progenitor cells.
A detailed comparison of gene expression signatures between ETP ALL tumors and and normal human
hematopoietic progenitor cells revealed a somewhat surprising finding: ETP - ALL expression patterns were less consistent with early T - cell precursors, as might have been expected, but more similar to the expression profile of normal hematopoietic stem cells and granulocyte macrophage precursors.
It's blood in a newborn baby's umbilical cord that's rich in a type of stem cell called
hematopoietic progenitor cells (HPCs).
Ana Fonseca (Corbeil, TUD)-- «New insights into cell migration and asymmetric cell division of human
hematopoietic progenitors» (2008)
The chemokine receptor CXCR - 4 is expressed on CD34 +
hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell - derived factor - 1.
New insights into the cell biology of
hematopoietic progenitors by studying prominin - 1 (CD133).
Additional in vitro and in vivo studies are needed to determine the cause of the specificity of JAK2V617F for myeloid diseases, as second mutations, host modifiers, differential cytokine receptor expression, and other factors may influence the ultimate phenotype of
hematopoietic progenitors that acquire the JAK2V617F mutation.
This observation suggests that activation of the JAK - STAT pathway and the RAS — mitogen - activated protein kinase (MAPK) pathway can cooperate in CMML, and suggests that the possibility that additional mutations in JAK2V617F mutant
hematopoietic progenitors may direct the eventual disease phenotype in specific patients.
Not exact matches
Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype
hematopoietic stem and
progenitor cells (HSPCs) into a mouse model of Friedreich's ataxia (FA) measurably halted cellular damage caused by the degenerative disease.
Human
hematopoietic stem and
progenitor cells (HSPCs), derived from bone marrow, have become a primary vehicle for efforts to replace or regenerate cells destroyed by a variety of diseases.
When Busch turned on the marker in adult animals, it became visible that at least one third (approximately 5000 cells) of a mouse's
hematopoietic stem cells produce differentiated
progenitor cells.
«Proper blood cell production is dependent on functioning
hematopoietic stem and
progenitor cells that are destroyed during conditioning procedures for transplantation or following bone marrow injury,» said the study's first author Kevin A. Goncalves, who performed this research as part of his PhD studies in cellular and molecular physiology at the Sackler School.
The findings were published in an article, «Angiogenin promotes
hematopoietic regeneration by dichotomously regulating quiescence of stem and
progenitor cells,» in the August 11, 2016 issue of the journal Cell.
She then followed up with a closer look at role of the Igf2 signaling pathway in coaxing quiescent
hematopoietic stem cells to start dividing and maturing into multi-lineage
progenitors that ultimately give rise to specialized blood cells.
Through gene therapy, researchers engineered blood - forming stem cells (
hematopoietic stem /
progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV - infected cells.
Earlier mouse studies by Li and his collaborators had indicated that the expression of several imprinted genes changes as
hematopoietic stem cells embark on their journey from quiescent reserve cells to multi-lineage
progenitor cells, which form the many highly specialized cell types that circulate within the blood stream.
Although many immunosuppressive strategies have failed, the recent use of autologous
hematopoietic stem and
progenitor cell (HSPC) transplantation has shown therapeutic promise.
Furthermore, these potentials are expanded by the notion that MSCs can exert functions other than those classically attributed to stem or
progenitor cells, including establishment and support of the
hematopoietic microenvironment in vivo, as observed for bone marrow derived MSCs.
Expression of the melanoma cell adhesion molecule in human mesenchymal stromal cells regulates proliferation, differentiation, and maintenance of
hematopoietic stem and
progenitor cells.
Recent evidence suggests the existence of
progenitor cells in adult tissues that are capable of differentiating into vascular structures as well as into all
hematopoietic cell lineages.
Bone marrow CD169 + macrophages promote the retention of
hematopoietic stem and
progenitor cells in the mesenchymal stem cell niche.
Regina Duryagina (Bornhäuser, TUD)-- «Role of Jagged - 1 and extracellular matrix components for the maintenance of
hematopoietic stem and
progenitor cells during ex-vivo expansion» (2013)
Immune cells are descendants of bone marrow - resident
hematopoietic stem cells (HSC) and are regenerated throughout life, thus, they have the unique capability to continuously regenerate but also to give rise to non-self renewing multipotent
progenitor cells.
Review of «Evaluating Interaction of Cord Blood
Hematopoietic Stem
Progenitor Cells with Functionally Integrated 3D microenvironments» from STEM CELLS Translational Medicine by Stuart P. Atkinson
While human cord blood represents a potentially important source of
hematopoietic stem and
progenitor cells (HSPC), current two dimensional (2D) growth conditions employed to amplify cell numbers to the level required for many regenerative applications lead to a decline in the absolute percentage of the most primitive HSPCs [1].
Recent papers published by groups from UC Berkeley and Stanford University have described methods for the genetic manipulation of primary human
hematopoietic stem and
progenitor cells (HSPCs) that require them to be maintained in vitro for anywhere from 24 hours to more than a week.
Review of «Safety and efficacy of a tCD25 pre-selective combination anti-HIV lentiviral vector in human
hematopoietic stem and
progenitor cells» from Stem Cells by Stuart P. Atkinson
HIV gene therapy hopes to confer HIV ‐ resistance to patients through the genetic manipulation of
hematopoietic stem /
progenitor cells (HSPCs)[1, 2].
Selection - free genome editing of the sickle mutation in human adult
hematopoietic stem /
progenitor cells.
Allogeneic cell therapies involving primary cell types such as bone marrow mesenchymal stromal / stem cells (BM - MSCs),
hematopoietic stem and
progenitor cells (HSPCs), and T and natural killer (NK) cells for immunotherapy applications are especially challenging because of the vigorous process of screening...
Title: The combination of valproic acid and lithium delays
hematopoietic stem /
progenitor cell differentiation Authors: Walasek MA, Bystrykh LV, van den Boom V, Olthof S, Ausema A, Ritsema M, Huls G, de Haan G and van Os R Date: 2012 Publication Details: Blood 2012 Mar 29; 119 (13): 3050 - 59
Functional rescue of dopaminergic neuron loss in Parkinson's disease mice after transplantation of
hematopoietic stem and
progenitor cells, EBioMedicine, in press.
In this work, we transplanted
hematopoietic stem and
progenitor cells into the substantia nigra of brains of two different mouse models of Parkinson's disease.
By transplanting Wnt - activated
hematopoietic stem and
progenitor cells (HSPCs) we demonstrated that Muller cells can be reprogrammed in vivo after fusion with HSPCs.
Zonari E, Desantis G, Petrillo C, Boccalatte FE, Lidonnici MR, Kajaste - Rudnitski A, Aiuti A, Ferrari G, Naldini L, Gentner B. Efficient ex vivo engineering and expansion of highly purified human
hematopoietic stem and
progenitor cell populations for gene therapy.
Dual actions of Meis1 inhibit erythroid
progenitor development and sustain general
hematopoietic cell proliferation.
Functional rescue of dopaminergic neuron loss in Parkinson's disease mice after transplantation of
hematopoietic stem and
progenitor cells.
We also analyzed the
hematopoietic stem cells and various
progenitor cells in the bone marrow.
Umbilical cord blood has a number of different types of cord stem cells, like endothelial
progenitor cells,
hematopoietic stem cells, and mesenchymal stem cells.